- Home
- ELTX vs STRW Comparison
ELTX vs STRW Comparison
Compare ELTX & STRW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELTX
- STRW
- Stock Information
- Founded
- ELTX 2011
- STRW 2015
- Country
- ELTX United States
- STRW United States
- Employees
- ELTX N/A
- STRW N/A
- Industry
- ELTX Biotechnology: Pharmaceutical Preparations
- STRW Real Estate Investment Trusts
- Sector
- ELTX Health Care
- STRW Real Estate
- Exchange
- ELTX Nasdaq
- STRW Nasdaq
- Market Cap
- ELTX 121.7M
- STRW 133.6M
- IPO Year
- ELTX N/A
- STRW N/A
- Fundamental
- Price
- ELTX $9.20
- STRW $10.21
- Analyst Decision
- ELTX Strong Buy
- STRW Strong Buy
- Analyst Count
- ELTX 2
- STRW 4
- Target Price
- ELTX $9.50
- STRW $12.72
- AVG Volume (30 Days)
- ELTX 47.4K
- STRW 62.1K
- Earning Date
- ELTX 08-12-2025
- STRW 08-11-2025
- Dividend Yield
- ELTX N/A
- STRW 5.47%
- EPS Growth
- ELTX N/A
- STRW 34.22
- EPS
- ELTX N/A
- STRW 0.58
- Revenue
- ELTX N/A
- STRW $126,557,000.00
- Revenue This Year
- ELTX N/A
- STRW $15.21
- Revenue Next Year
- ELTX N/A
- STRW $2.21
- P/E Ratio
- ELTX N/A
- STRW $17.76
- Revenue Growth
- ELTX N/A
- STRW 22.41
- 52 Week Low
- ELTX $3.70
- STRW $8.70
- 52 Week High
- ELTX $9.99
- STRW $12.90
- Technical
- Relative Strength Index (RSI)
- ELTX 68.72
- STRW 47.83
- Support Level
- ELTX $7.97
- STRW $10.09
- Resistance Level
- ELTX $8.94
- STRW $10.54
- Average True Range (ATR)
- ELTX 0.41
- STRW 0.40
- MACD
- ELTX 0.03
- STRW -0.03
- Stochastic Oscillator
- ELTX 96.74
- STRW 37.80
About ELTX Elicio Therapeutics Inc.
Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. It has developed its cancer vaccine product candidates to target biologically validated tumor mutation drivers using known neoantigens.
About STRW Strawberry Fields REIT Inc.
Strawberry Fields REIT Inc is a self-managed and self-administered company that specializes in the acquisition, ownership and triple-net leasing of skilled nursing facilities and other post-acute healthcare properties.